Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epirubicin and Paclitaxel +/- Capecitabine in Metastatic Breast Cancer
NCT01433614Phase 3Completed
- Start
- Dec 2002
- Primary completion
- Jun 2006
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of capecitabine in breast cancer. Started Dec 2002; status: completed.
02
Drugs
capecitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01433614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01433614.